Press "Enter" to skip to content

New patent expiration for Novartis drug TYKERB

1
Copyright © DrugPatentWatch. Originally published at New patent expiration for Novartis drug TYKERB

Annual Drug Patent Expirations for TYKERB
Annual Drug Patent Expirations for TYKERB

Tykerb is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There are three patents protecting this drug and one Paragraph IV challenge.

This drug has one hundred and thirty-eight patent family members in forty-eight countries.

The generic ingredient in TYKERB is lapatinib ditosylate. One supplier is listed for this compound. Additional details are available on the lapatinib ditosylate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent expiration for Novartis drug TYKERB
Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

Do NOT follow this link or you will be banned from the site!